Benralizumab in the Treatment of Patients With Severe Asthma With ABPA

Summary

Phase IV, open-label study will evaluate effects of Benralizumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis

Timeline

Start

2019-12-23

Primary completion

2021-09-24

Completion

2021-10-01

Publications

• Kao CC, Hanania NA, Parulekar AD. The impact of fungal allergic sensitization on asthma. Curr Opin Pulm Med. 2021 Jan;27(1):3-8. doi: 10.1097/MCP.0000000000000740.

Drugs

Indications